Table 3 Comparative cost analysis for clinical management of COVID-19 case with and without underlying diseases
From: Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis
Classification | Cost per case (USD, Mean ± SD) | P value | |
|---|---|---|---|
Without underlying diseases | With underlying diseases | ||
Laboratory diagnostics | 948 ± 536 | 1595 ± 856 | 0.001 |
Radiologic diagnostics | 216 ± 124 | 332 ± 172 | 0.001 |
Therapeutic measures | 951 ± 920 | 2882 ± 2940 | 0.001 |
Drug acquisition | 1375 ± 1832 | 4511 ± 4937 | < 0.001 |
Bed costs | 129 ± 53 | 208 ± 127 | 0.003 |
Total | 3619 ± 3243 | 9525 ± 8592 | 0.001 |